ArticleTherapeutic advances in medical oncology2026

Long-term complete remission following treatment with polatuzumab vedotin, rituximab, and bendamustine in a patient with mantle cell lymphoma relapsing after CAR-T cell therapy: a case report.

Vincent Sunder-Plassmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.